10x Genomics, Inc. is trading 1.5% up at $34.00 as the stock extends a strong multi-day rebound driven by technical strength and dip-buying interest.
- Shares have surged approximately 33% since May 27, signaling significant momentum despite a lack of new company-specific headlines.
- The move suggests a recovery from recent lows as investors capitalize on technical support, even amid softer sentiment in the broader technology sector.